These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1061 related articles for article (PubMed ID: 2154413)
1. Inhibitory effects of DN-9693 on platelet-enhanced tumor cell attachment to cultured endothelium. Tohgo A; Tanaka NG; Osada Y Invasion Metastasis; 1990; 10(1):1-17. PubMed ID: 2154413 [TBL] [Abstract][Full Text] [Related]
2. Effects of DN-9693, a new metastasis inhibitor, on murine hematogenous metastasis. Tanaka NG; Tohgo A; Ogawa H; Osada Y Anticancer Res; 1986; 6(4):543-8. PubMed ID: 3019218 [TBL] [Abstract][Full Text] [Related]
3. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Honn KV; Tang DG; Grossi IM; Renaud C; Duniec ZM; Johnson CR; Diglio CA Exp Cell Res; 1994 Jan; 210(1):1-9. PubMed ID: 8269984 [TBL] [Abstract][Full Text] [Related]
4. DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect. Jackson C; Ball J; Peel J; Lawry J; Greaves M; Preston FE Thromb Haemost; 1989 Apr; 61(2):266-9. PubMed ID: 2546286 [TBL] [Abstract][Full Text] [Related]
5. [Effects of platelet aggregating inhibitor on pulmonary metastases of tumor cells after surgical resection]. Yano S Hokkaido Igaku Zasshi; 1993 Sep; 68(5):654-63. PubMed ID: 8225173 [TBL] [Abstract][Full Text] [Related]
6. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions. Chopra H; Fligiel SE; Hatfield JS; Nelson KK; Diglio CA; Taylor JD; Honn KV Cancer Res; 1990 Dec; 50(23):7686-96. PubMed ID: 2253213 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors. Ashida S; Sakuma K Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259 [No Abstract] [Full Text] [Related]
8. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4. Blease K; Burke-Gaffney A; Hellewell PG Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364 [TBL] [Abstract][Full Text] [Related]
9. Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix. Menter DG; Steinert BW; Sloane BF; Gundlach N; O'Gara CY; Marnett LJ; Diglio C; Walz D; Taylor JD; Honn KV Cancer Res; 1987 Dec; 47(24 Pt 1):6751-62. PubMed ID: 2824041 [TBL] [Abstract][Full Text] [Related]
10. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
11. DN.9693, a phosphodiesterase inhibitor, compared with prostaglandin E1 and prostacyclin in four platelet "function" tests. O'Brien JR; Etherington MD; Salmon GP Thromb Res; 1988 Apr; 50(1):237-41. PubMed ID: 2840751 [No Abstract] [Full Text] [Related]
13. Role of adhesion molecules and platelets in TNF-induced adhesion of tumor cells to endothelial cells: implications for experimental metastasis. Stoelcker B; Hafner M; Orosz P; Nieswandt B; Männel DN J Inflamm; 1995-1996; 46(3):155-67. PubMed ID: 8844496 [TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors as antiplatelet agents in vascular surgery. Kambayashi J; Watase M; Kawasaki T; Shiba E; Sakon M; Mori T; Isaka Y; Kimura K; Kamada T Adv Second Messenger Phosphoprotein Res; 1992; 25():383-93. PubMed ID: 1313269 [No Abstract] [Full Text] [Related]
15. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process. Tang DG; Diglio CA; Honn KV Cancer Res; 1994 Feb; 54(4):1119-29. PubMed ID: 8313370 [TBL] [Abstract][Full Text] [Related]
16. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214 [TBL] [Abstract][Full Text] [Related]
17. Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse. Lichtner R; Haarmann W Prog Clin Biol Res; 1982; 89():131-41. PubMed ID: 6287486 [TBL] [Abstract][Full Text] [Related]
18. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Nicolson GL; Custead SE Cancer Res; 1985 Jan; 45(1):331-6. PubMed ID: 3965142 [TBL] [Abstract][Full Text] [Related]
19. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance. Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623 [TBL] [Abstract][Full Text] [Related]
20. Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Lou J; Donati YR; Juillard P; Giroud C; Vesin C; Mili N; Grau GE Am J Pathol; 1997 Nov; 151(5):1397-405. PubMed ID: 9358766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]